Physician profile
Riley J Williams
NPI 1598853863
$511,695.44
in general payments reported to CMS, 2019-2025
12 companies · $17K in 2025
The $17K reported for 2025 was more than what 90% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $2,797 · 2021: $2,423 · 2022: $401K · 2023: $35K · 2024: $3,210 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $46K · Royalty Or License: $8,963 · Food and Beverage: $636 · Entertainment: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $46,135.73 |
| Royalty Or License | $8,963.01 |
| Food and Beverage | $635.50 |
| Entertainment | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $444,620.02 | 2022-2025 | Engage Partial Knee System |
| Arthrex, INC. | $65,612.22 | 2019-2025 | Arthrex |
| Joint Restoration Foundation, INC. | $553.58 | 2019 | |
| Overture Orthopaedics | $459.71 | 2025 | Overtureti |
| Zimmer Biomet Holdings, INC. | $141.59 | 2020 | |
| Engage Uni, LLC | $114.00 | 2020 | |
| Native Surgical, LLC | $102.44 | 2025 | |
| Stryker Corporation | $57.87 | 2025 | Mako |
| Abbvie INC. | $19.73 | 2024 | |
| Sumitomo Pharma America, INC. | $14.28 | 2025 | Gemtesa |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,633,745.40 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riley Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.